InventisBio (SH:688382) Xin Lang Cai Jing·2025-09-08 02:32Group 1 - Yifang Biotechnology experienced a decline of 5.18% on September 8, with a stock price of 39.51 yuan per share and a trading volume of 1.48 billion yuan, resulting in a total market capitalization of 228.50 billion yuan [1] - The company, established on January 11, 2013, and listed on July 25, 2022, is located in the Shanghai Free Trade Zone and focuses on the research, production, and sales of innovative drugs, with 100% of its main business revenue coming from technology licensing and cooperation [1] Group 2 - According to data from the top ten holdings of funds, one fund under Shangyin Fund holds a significant position in Yifang Biotechnology, with the Shangyin Healthcare Mixed A Fund (011288) maintaining 375,700 shares, unchanged from the previous period, accounting for 5.71% of the fund's net value [2] - The Shangyin Healthcare Mixed A Fund, established on March 30, 2021, has a current size of 1.07 billion yuan and has achieved a year-to-date return of 61.67%, ranking 360 out of 8,248 in its category [2] - The fund manager, Yang Jiannan, has been in position for 3 years and 197 days, with the fund's total assets amounting to 216 million yuan, achieving a best return of 19.41% and a worst return of 18.15% during his tenure [2]